Potential in Radiosurgery Market: Accuray’s CyberKnife System is a robotic radiosurgery system capable of treating tumors throughout the body. An extensive body of published literature supports ...

Accuray (ARAY) announced that the company’s Radixact SynC System and CyberKnife S7 System have been approved by the Chinese National Medical Products Administration. “With these approvals ...

Interest in both the company’s Tomo C system and more advanced offerings (including the CyberKnife) appears to be healthy. While Elekta has been making claims of share growth in China ...

The company has a P/S ratio of 0.5 compared with the industry’s 3.1. Image Source: Zacks Investment Research Potential in Radiosurgery Market: Accuray’s CyberKnife System is a robotic ...

The company has a P/S ratio of 0.5X compared with the industry’s 4.4X. Potential in Radiosurgery Market: Accuray’s CyberKnife System is a robotic radiosurgery system capable of treating tumors ...

Image Source: Zacks Investment Research Potential in Radiosurgery Market: Accuray’s CyberKnife System is a robotic radiosurgery system capable of treating tumors throughout the body. An ...

The company has a P/S ratio of 0.5 compared with the industry’s 3.1. Potential in Radiosurgery Market: Accuray’s CyberKnife System is a robotic radiosurgery system capable of treating tumors ...